MSB 2.51% 97.0¢ mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-2

  1. 1,051 Posts.
    lightbulb Created with Sketch. 168
    Thank you MSB for taking a proactive approach. I am a buyer this morning. This is not financial advice.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.